11.37
Anika Therapeutics Inc stock is traded at $11.37, with a volume of 36,347.
It is up +3.82% in the last 24 hours and up +4.58% over the past month.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
See More
Previous Close:
$11.00
Open:
$11.11
24h Volume:
36,347
Relative Volume:
0.44
Market Cap:
$163.78M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-2.2426
EPS:
-5.07
Net Cash Flow:
$1.14M
1W Performance:
+2.06%
1M Performance:
+4.58%
6M Performance:
-30.24%
1Y Performance:
-59.26%
Anika Therapeutics Inc Stock (ANIK) Company Profile
Name
Anika Therapeutics Inc
Sector
Phone
(781) 457-9000
Address
32 WIGGINS AVENUE, BEDFORD, MA
Compare ANIK with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ANIK
Anika Therapeutics Inc
|
11.42 | 157.76M | 166.88M | -74.18M | 1.14M | -5.07 |
![]()
ZTS
Zoetis Inc
|
152.69 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.75 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.51 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
305.26 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-17-25 | Initiated | B. Riley Securities | Buy |
Nov-01-24 | Reiterated | Barrington Research | Outperform |
Aug-14-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Mar-07-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Nov-09-22 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Oct-14-22 | Resumed | Stephens | Equal-Weight |
Mar-09-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Mar-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
Nov-16-21 | Initiated | Stephens | Overweight |
Jul-16-21 | Initiated | UBS | Neutral |
Dec-16-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
May-08-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Jan-21-20 | Upgrade | Sidoti | Neutral → Buy |
Jan-10-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
Nov-05-19 | Initiated | BWS Financial | Sell |
Sep-24-19 | Reiterated | Barrington Research | Outperform |
Sep-23-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Strong Buy |
Feb-22-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
Feb-22-19 | Downgrade | Sidoti | Buy → Neutral |
Jul-27-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Jun-20-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Jun-20-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
May-04-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Feb-23-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Jan-24-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
Oct-27-17 | Reiterated | Barrington Research | Outperform |
May-09-16 | Upgrade | Singular Research | BUY - Long-Term → Buy |
Apr-27-16 | Downgrade | Northland Capital | Outperform → Market Perform |
Feb-26-16 | Reiterated | Barrington Research | Outperform |
View All
Anika Therapeutics Inc Stock (ANIK) Latest News
What drives Anika Therapeutics Inc. stock priceSkyrocketing returns - Autocar Professional
Is Anika Therapeutics Inc. a good long term investmentExponential return rates - Autocar Professional
What analysts say about Anika Therapeutics Inc. stockRapid wealth multiplication - jammulinksnews.com
Anika Therapeutics Inc. Stock Analysis and ForecastTriple returns potential - jammulinksnews.com
Why Anika Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser
Will Anika Therapeutics Inc. stock benefit from AI tech trendsROI Driven Alerts - Newser
Why Anika Therapeutics Inc. stock is on top investor watchlistsLow Risk Profit Ideas - Newser
Published on: 2025-07-17 22:25:16 - Newser
how anika therapeutics inc. stock performs during market volatilityLow Risk Scalping Alerts - Newser
Anika Therapeutics: Orthopedic Growth and Pipeline Progress Amid Headwinds - AInvest
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 - GlobeNewswire
Orthopedics Leader Anika Announces Q2 2025 Earnings Call: Key Financial Results Coming July 30 - Stock Titan
How Anika Therapeutics Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
What makes Anika Therapeutics Inc. stock price move sharplyDaily Gain Forecast - Newser
Anika Therapeutics Inc. (NASDAQ:ANIK) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Breakthrough Growth Ahead: Adhesion Barrier Market Set to Surge - openPR.com
Europe Viscosupplementation Market Growth in Future Scope - openPR.com
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
(ANIK) Technical Data - news.stocktradersdaily.com
Anika Therapeutics, Inc.(NasdaqGS: ANIK) dropped from Russell Microcap Growth Index - MarketScreener
Anika Therapeutics, Inc.(NasdaqGS:ANIK) dropped from Russell 2000 Growth-Defensive Index - MarketScreener
Anika Therapeutics, Inc.(NasdaqGS:ANIK) dropped from Russell Small Cap Comp Growth Index - MarketScreener
ANIK SEC FilingsAnika Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Anika Therapeutics Approves Key Proposals at Annual Meeting - TipRanks
Anika Therapeutics stockholders approve incentive plan amendment and elect directors - Investing.com
Comparing Vivos (OTCMKTS:RDGL) & Anika Therapeutics (NASDAQ:ANIK) - Defense World
Two Sigma Investments LP Cuts Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Bank of America Corp DE Boosts Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics Inc Stock (ANIK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anika Therapeutics Inc Stock (ANIK) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):